Oxford Finance offered debt funding for the deal. Credit: Markus Winkler on Unsplash

Investment company SAIGroup has announced the acquisition of Get Well, a company specialising in digital patient engagement.

Financial details regarding the transaction were not revealed.

Get Well is known for facilitating over ten million patient interactions annually across more than one thousand healthcare organisations. The company will now become part of SAIGroup’s AI healthcare portfolio, which includes companies like ConcertAI and RhythmX AI.

With the integration of SAIGroup’s Eureka AI platform, Get Well aims to enhance patient experience both within and outside hospital settings.

The collaboration with SAIGroup’s RhythmX AI platform, which has access to extensive healthcare data, will enable Get Well to improve the patient and clinician experience. This data includes longitudinal metadata from 300 million patients, over 4.4 billion total annual claims, and profiles of more than 1.8 million healthcare professionals.

See Also:

The use of predictive and generative AI is expected to enhance clinician efficiency and provide precision care recommendations.

SAIGroup founder and CEO Dr. Romesh Wadhwani will take on the role of chairman at Get Well, while Michael O’Neil will continue as the founder and CEO.

Oxford Finance offered debt funding for the deal, with McDermott Will & Emery and Cain Brothers serving as legal counsel to SAIGroup and Get Well, respectively.

Michael O’Neil stated: “The AI capabilities of SAIGroup will enable Get Well to accelerate our innovation roadmap and transform how healthcare providers care for and interact with patients.”

Dr. Wadhwani added: “As part of SAIGroup, Get Well’s mission to enable the best patient experience will undergo a rapid transformation with AI to a full precision care platform for hospitals and ambulatory centres.”

Get Well has a track record of enhancing digital patient engagement for major health systems, including Adventist Health and Kaiser Permanente.

The company’s solutions have reportedly led to over 40% and 36% reductions in readmission rates and preterm births respectively, as well as double-digit growth in brand loyalty metrics.